Mentax and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is reported as a side effect among people who take Mentax (butenafine hydrochloride), especially for people who are male, 60+ old, also take Lyrica, and have Osteoporosis.

The phase IV clinical study analyzes which people have Oedema peripheral when taking Mentax. It is created by eHealthMe based on reports of 275 people who have side effects when taking Mentax from the FDA, and is updated regularly.

What is Mentax?

Mentax has active ingredients of butenafine hydrochloride. eHealthMe is studying from 283 Mentax users. Check the latest studies of Mentax.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,773 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

275 people reported to have side effects when taking Mentax.
Among them, 11 people (4.0%) have Oedema peripheral.

Among these 11 people:

What is the gender of people who have Oedema peripheral when taking Mentax? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Oedema peripheral when taking Mentax? *

What are other drugs people take besides Mentax? *

What are other side effects people have besides Oedema peripheral? *

Joint Pain: 8 people, 72.73%
Pain In Extremity: 8 people, 72.73%
Abasia (inability to walk): 7 people, 63.64%
Weight Bearing Difficulty (difficulty due to weight of thigh fat deposition): 7 people, 63.64%
Foot Deformity (functional disability of foot): 7 people, 63.64%
Pain: 7 people, 63.64%
Bone Pain: 7 people, 63.64%
Balance Disorder: 4 people, 36.36%
Neuropathic Arthropathy (a progressive destruction of bone and joints): 4 people, 36.36%
Constipation: 2 people, 18.18%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 63.64%
Type 2 Diabetes: 1 person, 9.09%
Tinea Infection (fungal skin infection): 1 person, 9.09%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 9.09%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 9.09%
Hyperkeratosis (thickening of the outer layer of the skin): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Heart Disease: 1 person, 9.09%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 9.09%
Gastric Ulcer (stomach ulcer): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mentax and have Oedema peripheral?

- Check whether Oedema peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mentax:

Mentax (283 reports)

Oedema peripheral treatments and more:

Oedema peripheral (172,690 reports)

Browse all side effects of Mentax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema peripheral:

Oedema peripheral (2,773 drugs)

Browse all the conditions that are associated with Oedema peripheral:

Oedema peripheral (3,465 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on butenafine hydrochloride (the active ingredients of Mentax) and Mentax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.